Good Manufacturing Practice (GMP) is the foundation of quality and regulatory compliance in the healthcare manufacturing industry. For clinicians, pharmacists, and suppliers, GMP assures that medicines and therapeutic goods are produced under consistent and controlled conditions.
This article examines GMP principles, their significance in healthcare and medicinal cannabis, and how tools like The Compendium facilitate more informed decision-making.
Good Manufacturing Practice (GMP) sets out manufacturing standards designed to ensure products are consistently produced and controlled to established quality benchmarks. These guidelines cover every stage of production, from raw materials through to final packaging.
Importantly, GMP does not rely on a single endpoint test. Instead, it requires manufacturers to build quality into each step through validated processes, clear documentation, and strict oversight. In Australia, the Therapeutic Goods Administration (TGA) oversees GMP compliance for medicines and other regulated products, ensuring these standards are consistently met.
The TGA highlights that GMP helps safeguard the integrity of therapeutic goods. It does so through several core principles, including:
Standard Operating Procedures (SOPs): Written instructions guide every process that may affect product quality.
Validated Facilities and Equipment: Manufacturing spaces and equipment are designed, qualified, and maintained to ensure consistent performance.
Controlled Materials: Ingredients and packaging materials are tested, tracked, and managed for full traceability.
Process Control and Testing: Manufacturers validate critical steps and carry out in-process checks throughout production.
Documentation and Recordkeeping: Organisations maintain complete, accurate, and readily available records for review.
Personnel Training: Staff are appropriately qualified and receive ongoing training to meet regulatory requirements.
Together, these measures support a broader Quality Management System (QMS), ensuring quality and compliance are maintained across all stages of production.
In Australia, medicine manufacturers must hold a licence and demonstrate GMP compliance through Therapeutic Goods Administration (TGA) inspections. Likewise, overseas suppliers importing into Australia must provide evidence of GMP certification that meets recognised standards.
For medicinal cannabis, requirements are equally stringent. Producers must obtain the appropriate licences under the Therapeutic Goods Act 1989 and, if relevant, under the Narcotic Drugs Act 1967. In addition, imported products must originate from facilities that comply with approved GMP standards.
If organisations fail to comply, regulators can take enforcement action. This may include product recalls, suspension of supply, or other restrictions designed to protect patient safety and maintain regulatory integrity.
GMP forms part of a broader quality framework. A Quality Management System (QMS) provides a structured set of processes and controls that support consistent manufacturing outcomes and compliance with regulatory requirements (TGA).
Manufacturers implement a QMS to ensure processes are documented, controlled, and continuously reviewed in line with applicable standards (TGA). Key elements typically include:
A quality manual and documented policies
Standard operating procedures (SOPs)
Staff training programs
Regular management reviews and audits
Overall, a QMS helps maintain consistency across product design, manufacturing, and distribution. In addition, it supports structured change control and validation protocols when adjustments are required.
Accurate recordkeeping is essential in GMP environments. Good Documentation Practice (GDocP) refers to requirements that records be complete, legible, contemporaneous, and securely maintained (PharmOut).
In practice, this involves following the ALCOA+ principles:
These principles ensure records are reliable and accessible for audits and regulatory reviews.
GMP sits within the broader family of GxP practices, which also includes:
GLP – Good Laboratory Practice
GCP – Good Clinical Practice
GDP – Good Distribution Practice
Each framework focuses on maintaining quality and compliance across different stages of the product lifecycle (Microsoft Learn). Together, GxP standards provide a structured approach that ensures processes consistently meet regulatory expectations.
For clinicians, pharmacists, and suppliers, GMP compliance builds confidence in prescribing and dispensing decisions.
Clinicians: Using The Compendium, prescribers can compare GMP-compliant products side by side, check real-time availability, and filter options by dosage form or cannabinoid profile.
Pharmacists: In addition, visibility of stock levels within The Compendium helps reduce last-minute prescription changes and ensures medicines are dispensed without unnecessary delays.
Suppliers: Similarly, GMP certification strengthens trust with prescribers. By sharing updates directly within The Compendium, suppliers keep product information clear, accurate, and easy to access.
Overall, while GMP does not guarantee individual patient outcomes, it provides a consistent framework for product quality across the industry.
Good Manufacturing Practice (GMP) underpins trust in therapeutic goods by ensuring consistent quality and regulatory compliance. In the medicinal cannabis sector, GMP plays a critical role in maintaining product quality, safety and consistency at every stage of the supply chain.
Furthermore, platforms like The Compendium support healthcare professionals by providing structured access to essential product information, including compliance details and stock availability. As a result, clinicians, pharmacists and suppliers can make timely, informed decisions while upholding high standards across the industry.
